B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis

European Journal of Immunology

Volumn 36, Issue 7, 2006, Pages 1867-1881

  Gómez, Patricia ^a   Montserrat, Verónica ^a   Marcilla, Miguel ^a   Paradela, Alberto ^a   López de Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Ankylosing spondylitis; HLA B27; Peptides

Indexed keywords

ALLOANTIGEN; ASPARTIC ACID; EPITOPE; HLA B27 ANTIGEN; LIGAND; PEPTIDE; HLA B 2705 ANTIGEN; HLA B ANTIGEN; HLA B*2704 ANTIGEN; HLA B*2707 ANTIGEN; HLA-B 2705 ANTIGEN; HLA-B*2704 ANTIGEN; HLA-B*2707 ANTIGEN;

ALLOTYPE; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; CELL LINE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN MOTIF; SPONDYLARTHRITIS;

AMINO ACID MOTIFS; CELL LINE; EPITOPES, T-LYMPHOCYTE; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; PEPTIDES; PROTEIN BINDING; SPONDYLARTHRITIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33746217869     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200635896     Document Type: Article

References (57)

1. Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. and Sturrock, R. D., Ankylosing spondylitis and HL-A 27. Lancet 1973. 1: 904-907.
2. Schlosstein, L., Terasaki, P. I., Bluestone, R. and Pearson, C. M., High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 1973. 288: 704-706.
3. Ramos, M. and Lopez de Castro, J. A., HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 2002. 60: 191-205.
4. Colbert, R. A., The immunobiology of HLA-B27: Variations on a theme. Curr. Mol. Med. 2004. 4: 21-30.
5. Benjamin, R. and Parham, P., Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 1990. 11: 137-142.
6. Ruckert, C., Fiorillo, M. T., Loll, B., Moretti, R., Biesiadka, J., Saenger, W., Ziegler, A. et al., Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J. Biol. Chem. 2005. 281: 2306-2316.
7. Kollnberger, S., Bird, L., Sun, M. Y., Retiere, C., Braud, V. M., McMichael, A. and Bowness, P., Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum. 2002. 46: 2972-2982.
8. Bird, L. A., Peh, C. A., Kollnberger, S., Elliott, T., McMichael, A. J. and Bowness, P., Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 2003. 33: 748-759.
9. Allen, R. L., Raine, T., Haude, A., Trowsdale, J. and Wilson, M. J., Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 2001. 167: 5543-5547.
10. Mear, J. P., Schreiber, K. L., Münz, C., Zhu, X., Stevanovic, S., Rammensee, H. G., Rowland-Jones, S. L. and Colbert, R. A., Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 1999. 163: 6665-6670.
11. Dangoria, N. S., Delay, M. L., Kingsbury, D. J., Mear, J. P., Uchanska-Ziegler, B., Ziegler, A. and Colbert, R. A., HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 2002. 277: 23459-23468.
12. Colbert, R. A., HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum? Mol. Med. Today 2000. 6: 224-230.
13. Turner, M. J., Sowders, D. P., Delay, M. L., Mohapatra, R., Bai, S., Smith, J. A., Brandewie, J. R. et al., HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J. Immunol. 2005. 175: 2438-2448.
14. Lopez-Larrea, C., Sujirachato, K., Mehra, N. K., Chiewsilp, P., Isarangkura, D., Kanga, U., Dominguez, O. et al., HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995. 45: 169-176.
15. Ren, E. C., Koh, W. H., Sim, D., Boey, M. L., Wee, G. B. and Chan, S. H., Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens 1997. 49: 67-69.
16. Nasution, A. R., Mardjuadi, A., Kunmartini, S., Suryadhana, N. G., Setyohadi, B., Sudarsono, D., Lardy, N. M. and Feltkamp, T. E., HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J. Rheumatol. 1997. 24: 1111-1114.
17. D'Amatu, M., Fiorillo, M. T., Carcassi, C., Mathieu, A., Zuccarelli, A., Bitti, P. P., Tosi, R. and Sorrentino, R., Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 1995. 25: 3199-3201.
18. Mathieu, A. and Sorrentino, R., HLA-B*2709 and spondylarthropathies: Comment on the concise communication by Olivieri et al. Arthritis Rheum. 2003. 48: 866-867.
19. Chen, I. H., Yang, K. L., Lee, A., Huang, H. H., Lin, P. Y. and Lee, T. D., Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur. J. Immunogenet. 2002. 29: 435-438.
20. Lopez de Castro, J. A., Alvarez, I., Marcilla, M., Paradela, A., Ramos, M., Sesma, I. and Vazquez, M., HLA-B27: A registry of constitutive peptide ligands. Tissue Antigens 2004. 63: 424-445.
21. Garcia, F., Marina, A. and Lopez de Castro, J. A., Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 1997. 49: 215-221.
22. Fiorillo, M. T., Meadows, L., D'Amato, M., Shabanowitz, J., Hunt, D. F., Apella, E. and Sorrentino, R., Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 1997. 27. 368-373.
23. Sesma, L., Montserrat, V., Lamas, J. R., Marina, A., Vazquez, J. and Lopez de Castro, J. A., The peptide repertoires of HLA-B27 subtypes differentially associated to spondyloarthropathy (B*2704 and B*2706) differ by specific changes at three anchor positions. J. Biol. Chem. 2002. 277: 16744-16749.
24. Ramos, M., Paradela, A., Vazquez, M., Marina, A., Vazquez, J. and Lopez de Castro, J. A., Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J. Biol. Chem. 2002. 277: 28749-28756.
25. Gonzalez-Roces, S., Alvarez, M. V., Gonzalez, S., Dieye, A., Makni, H., Woodfield, D. G., Housan, L. et al., HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997. 49: 116-123.
26. Garcia-Fernandez, S., Gonzalez, S, Mina, B. A., Martinez-Borra, J., Blanco-Gelaz, M., Lopez-Vazquez, A. and Lopez-Larrea, C., New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001. 58: 259-262.
27. Paladini, F., Taccari, E., Fiorillo, M. T., Cauli, A., Passiu, G., Mathieu, A., Punzi, L. et al., Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum. 2005. 52: 3319-3321.
28. Oguz, F. S., Ocal, L., Diler, A. S., Ozkul, H., Asicioglu, F., Kasapoglu, E., Bozkurt, G. et al., HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis. Markers 2004. 20: 309-312.
29. Tieng, V., Dulphy, N., Boisgérault, F., Tamouza, R, Charron, D. and Toubert, A., HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. Immunogenetics 1997. 47: 103-105.
30. Varnavidou-Nicolaidou, A., Karpasitou, K., Georgiou, D., Stylianou, G., Kokkofitou, A., Michalis, C., Constantina, C. et al., HLA-B27 in the Greek Cypriot population: Distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum. Immunol. 2004. 65: 1451-1454.
31. Heath, W. R., Kane, K. P., Mescher, M. F. and Sherman, L. A., Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 1991. 88: 5101-5105.
32. Rotzschke, O., Falk, K., Faath, S. and Rammensee, H. G., On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 1991. 174: 1059-1071.
33. Wang, W., Man, S., Gulden, P. H., Hunt, D. F. and Engelhard, V. H., Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 1998. 160: 1091-1097.
34. Merino, E., Montserrat, V., Paradela, A. and Lopez de Castro, J. A., Two HLA-B14 subtypes (B-1402 and B-1403) differentially associated with ankylosing spondylitis differ substantially in peptide specificity, but have limited peptide and T-cell epitope sharing with HLA-B27. J. Biol. Chem. 2005. 280: 35868-35880.
35. Hüllsmeyer, M., Fiorillo, M. T., Bettosini, F., Sorrentino, R., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 2004. 199: 271-281.
36. Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. and Eisen, H. N., Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996. 4: 565-571.
37. Goodall, J. C., Ellis, L. and Hill Gaston, J. S., Spondylarthritis-associated and non-spondylarthritis-associated B27 subtypes differ in their dependence upon tapasin for surface expression and their incorporation into the peptide loading complex. Arthritis Rheum 2006. 54: 138-147.
38. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M. and Sette, A., Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993. 74: 929-937.
39. Loll, B., Zawacka, A., Biesiadka, J., Petter, C., Ruckert, C., Saenger, W., Uchanska-Ziegler, B. and Ziegler, A., Preliminary X-ray diffraction analysis of crystals from the recombinantly expressed human major histocompatibility antigen HLA-B*2704 in complex with a viral peptide and with a self-peptide. Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun. 2005. 61: 939-941.
40. Zawacka, A., Loll, B., Biesiadka, J., Saenger, W., Uchanska-Ziegler, B. and Ziegler, A., X-ray diffraction analysis of crystals from the human major histocompatibility antigen HLA-B*2706 in complex with a viral peptide and with a self-peptide. Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun. 2005. 61: 1097-1099.
41. Hülsmeyer, M., Hilling, R. C., Volz, A., Rühl, M., Schröder, W., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 2002. 277: 47844-47853.
42. Hillig, R. C., Huelsmeyer, M., Saenger, W., Welfle, K., Misselwitz, R., Welfle, H., Kozerski, C. et al., Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 2004. 279: 652-663.
43. Fiorillo, M. T., Ruckert, C., Hulsmeyer, M., Sorrentino, R., Saenger, W., Ziegler, A. and Uchanska-Ziegler, B., Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 2005. 280: 2962-2971.
44. Hulsmeyer, M., Welfle, K., Pohlmann, T., Misselwitz, R., Alexiev, U., Welfle, H., Saenger, W. et al., Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J. Mol. Biol. 2005. 346: 1367-1379.
45. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., Rothbard, J. B. and Allen, P. M., Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous ligands. Immunity 1995. 2: 655-663.
46. Paradela, A., Garcia-Peydro, M., Vazquez, J., Rognan, D. and Lopez de Castro, J. A., The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: Role of peptide and the MHC molecule in alloreactivity. J. Immunol. 1998. 161: 5481-5490.
47. Garcia-Peydro, M., Marti, M. and Lopez de Castro, J. A., High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis. J. Immunol. 1999. 163: 2299-2305.
48. Garcia, F., Rognan, D., Lamas, J. R., Marina, A. and Lopez de Castro, J. A., An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 1998. 58: 1-9.
49. Fiorillo, M. T., Maragno, M., Butler, R., Dupuis, M. L. and Sorrentino, R., CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest 2000. 106: 47-53.
50. Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R. and Cresswell, P., NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 1987. 138: 1657-1659.
51. Zemmour, J., Little, A. M., Schendel, D. J. and Parham, P., The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 1992. 148: 1941-1948.
52. Vázquez, M. N. and Lopez de Castro, J. A., Similar cell surface expression of β2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum. 2005. 52: 3290-3299.
53. Calvo, V., Rojo, S., Lopez, D., Galocha, B. and Lopez de Castro, J. A., Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J. Immunol. 1990. 144: 4038-4045.
54. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Ziegler, A., Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978. 14: 9-20.
55. Paradela, A., Alvarez, I., Garcia-Peydro, M., Sesma, L., Ramos, M., Vazquez, J. and Lopez de Castro, J. A., Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J. Immunol. 2000. 164: 329-337.
56. Lopez, D., Garcia Hoyo, R. and Lopez de Castro, J. A., Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J. Immunol. 1994. 152: 5557-5571.
57. Shankarkumar, U., Ghosh, K. and Mohanty, D., HLA B27 polymorphism in Western India. Tissue Antigens 2002. 60: 98-101.